Założenie: listopad 2008
Siedziba: Boston, Massachusetts
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare ...
Więcej pytań
Is RYTM a buy or sell?
What is the price target for rhythm pharmaceuticals?
What is the forecast for rhythm pharmaceuticals?
Is Rhythm Pharmaceuticals public?
We're dedicated to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) ...
Rhythm Pharmaceuticals Inc / Cena akcji
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment ...
Eight voice analog drum computer & sampler. Layer distinctive analog percussion with digital samples. Bring in the power of sequencing and performance controls.
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on advancing its melanocortin-4 receptor (MC4R) ...
NASDAQ: RYTM. $39.68 0 (0.00%). Data Provided by Refinitiv. Minimum 15 minutes ... Rhythm's stock is traded on the NASDAQ Global Market under the symbol RYTM.
RYTM | Complete Rhythm Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Ocena
(8)
The average price target for Rhythm Pharmaceuticals Inc is $56.25. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare ...
Rhythm Pharmaceuticals, Inc.'s stock symbol is RYTM and currently trades under NASDAQ. It's current price per share is approximately $39.65.